NAICS 62221 - Psychiatric and Substance Abuse Hospitals
NAICS 62221 - PSYCHIATRIC AND SUBSTANCE ABUSE HOSPITALS
View full description Collapse full description
This industry comprises establishments known and licensed as psychiatric and substance abuse hospitals primarily engaged in providing diagnostic, medical treatment, and monitoring services for inpatients who suffer from mental illness or substance abuse disorders.
The treatment often requires an extended stay in the hospital.
These establishments maintain inpatient beds and provide patients with food services that meet their nutritional requirements. They have an organized staff of physicians and other medical staff to provide patient care services. Psychiatric, psychological, and social work services are available at the facility.
These hospitals usually provide other services, such as outpatient services, clinical laboratory services, diagnostic X-ray services, and electroencephalograph services.
Explore the industry hierarchy
Drill down to explore more specific industries.
Industry trends
The psychiatric and substance abuse hospital industry, classified under NAICS 62221, is undergoing significant qualitative trends that are reshaping its landscape. One prominent trend is the increasing integration of telehealth services. This shift has been accelerated by the COVID-19 pandemic, leading to a growing acceptance and reliance on virtual consultations and remote patient monitoring. Telehealth's convenience and accessibility make it a valuable tool for ongoing psychiatric and substance abuse treatment.
There is also a heightened focus on holistic and personalized care approaches. Hospitals are incorporating comprehensive treatment plans that address not only the psychiatric and substance abuse issues but also the associated social, psychological, and emotional factors. This trend is driven by the recognition that multi-dimensional care significantly improves patient outcomes.
Additionally, there is a growing emphasis on the use of data analytics and artificial intelligence (AI). These technologies are being utilized to enhance patient care through predictive analytics, personalized treatment recommendations, and improved patient management systems. AI, for example, can help in identifying early indicators of relapse in substance abuse patients, allowing for timely intervention.
Looking to the near future, these trends are expected to continue and evolve. Regulatory support for telehealth services may increase, further entrenching its role in psychiatric and substance abuse care. Investments in AI and data analytics tools are also likely to grow, with a focus on improving precision medicine. Lastly, holistic care models may become a standard practice as the industry recognizes the necessity of addressing the full spectrum of factors impacting mental health and substance abuse recovery.
- Investment in renewable energy and grid modernization continues to accelerate.
- Regulatory changes and sustainability initiatives are shaping long-term growth.
- Operational efficiency and technology adoption are key focus areas.
Get the Full Industry Report
In-depth analysis, 50+ financial ratios, 4-year trends, and industry forecasts.